ADC Therapeutics SA
NYSE · Healthcare · Pharmaceutical Preparations · Epalinges, Switzerland
ADCT chart
What traders are saying about $ADCT
Latest postsADC Therapeutics SA news
- ADC Therapeutics SA (ADCT) Discusses ZYNLONTA Data at ASH and Strategic Financial Restructuring - Slideshow
Seeking Alpha ·
- ADC Therapeutics SA (ADCT) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
- AIGH Capital Management LLC Acquires New Shares in ADC Therapeutics SA $ADCT
MarketBeat ·
- BioAge Labs, Inc. (BIOA) Reports Q3 Loss, Misses Revenue Estimates
Yahoo Finance ·
- FDA Approval for ZYNLONTA issued to ADC Therapeutics SA
Quantisnow ·
- ADC Therapeutics Reports Strong Lymphoma Responses, Plans Phase III Study
marketbeat.com ·
- ADC Therapeutics Announces Abstracts at the 68th ASH Annual Meeting Highlighting Breadth of ZYNLONTA® Clinical Program
Yahoo Finance ·
- A lymphoma drug combination had an 88.7% response rate among 97 patients assessed.
Stock Titan ·
- ADC Therapeutics to Present at November Investor Conferences
Yahoo Finance ·
- ADC Therapeutics Announces New Employee Inducement Grant
Yahoo Finance ·
- ADC Therapeutics to Announce Third Quarter 2026 Financial Results on November 9, 2026
Yahoo Finance ·
- Full financial results will be posted online by ADC Therapeutics on Nov. 9.
Stock Titan ·
ADC Therapeutics SA key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $81.4M | $70.8M | $69.6M | $209.9M |
| Net income | -$142.6M | -$157.8M | -$240.1M | -$157.1M |
| Diluted EPS | $-1.12 | $-1.62 | $-2.94 | $-2.01 |
| Total assets (year end) | $323.1M | $322.0M | $354.8M | $490.9M |
| Cash and equivalents (year end) | $261.3M | $250.9M | $278.6M | $326.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About ADC Therapeutics SA
- Ticker
- ADCT (NYSE)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Epalinges, Switzerland
- Incorporated in
- Switzerland
- Fiscal year end
- December 31
- SEC CIK
- 1771910
Frequently asked questions
What exchange is ADC Therapeutics SA listed on?
ADC Therapeutics SA trades on the NYSE under the ticker symbol ADCT.
What industry is ADC Therapeutics SA in?
ADC Therapeutics SA is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is ADC Therapeutics SA headquartered?
ADC Therapeutics SA's business address on file with the SEC is in Epalinges, Switzerland.
When does ADC Therapeutics SA's fiscal year end?
ADC Therapeutics SA's fiscal year ends on December 31.
How much revenue did ADC Therapeutics SA report?
ADC Therapeutics SA reported $81.4M in revenue for calendar year 2025, according to its SEC filings.